Rankings / Immune & Inflammation
Akkermansia muciniphila (pasteurized)
Immune & Inflammation · Next-generation probiotic
Tier B
Bottom line
Read Off Label grades Akkermansia muciniphila (pasteurized) as B (6.8/10) based on moderate evidence, low-med benefit magnitude, and a low-risk safety profile.
Paradoxically, pasteurized (heat-killed) preparations had better metabolic effects than live bacteria in Depommier trials.
Studied, labeled, or reported-use context: ~10^10 pasteurized cells/day PO — OTC; not individualized guidance.
What the evidence says
Paradoxically, pasteurized (heat-killed) preparations had better metabolic effects than live bacteria in Depommier trials. Commercial products (Pendulum, others) now available. Small effect sizes on glucose and lipids in short trials. A 2026 Nature Medicine RCT extended the evidence to weight-loss maintenance, with results consistent with a modest supportive effect. Expensive.
Mechanism
Gram-negative mucin-degrading bacterium; depleted in obesity, metabolic syndrome, IBD; pasteurized form (non-viable) retains Amuc_1100 outer membrane protein that mediates metabolic benefits via TLR2
Studied, labeled, or reported dose & route
~10^10 pasteurized cells/day PO
This records doses and routes described in studies, approved labeling, clinical practice, or documented use. It is not individualized guidance and does not establish safety; context changes with indication, formulation, health history, monitoring, and other medicines.
Citations
A link means the source informed this entry; it does not mean every claim on the page comes from that source. If a citation looks wrong or you want a claim re-checked, send a correction.
Common questions
- What does the evidence show about Akkermansia muciniphila (pasteurized)'s effects?
- Read Off Label rates the evidence for Akkermansia muciniphila (pasteurized) as Moderate and the benefit magnitude as low-med, producing an overall grade of B (6.8/10). Paradoxically, pasteurized (heat-killed) preparations had better metabolic effects than live bacteria in Depommier trials.
- What safety findings are reported for Akkermansia muciniphila (pasteurized)?
- Akkermansia muciniphila (pasteurized) has a low risk profile in the database. Low (pasteurized form considered safer than live Akkermansia for immunocompromised) Legal status: OTC (Pendulum Glucose Control and similar in US).
- What doses or routes are reported for Akkermansia muciniphila (pasteurized)?
- ~10^10 pasteurized cells/day PO This is context from studies, approved labeling, clinical practice, or documented use; it is not individualized guidance and does not establish safety.
- How does Akkermansia muciniphila (pasteurized) work?
- Gram-negative mucin-degrading bacterium; depleted in obesity, metabolic syndrome, IBD; pasteurized form (non-viable) retains Amuc_1100 outer membrane protein that mediates metabolic benefits via TLR2
This is an independent synthesis of published research by a non-clinician. Scores are opinions supported by citations, not prescriptions. See the full disclaimer and methodology for how this score was produced and what it does and doesn't mean.